The Enterprise Value as of November 2024 (TTM) for BioNTech SE (BNTX) is 16.64B

According to BioNTech SE’s latest financial reports and current stock price. The company's current Enterprise Value is 16.64B. This represents a change of 41.40% compared to the average of 11.77B of the last 4 quarters.

BioNTech SE (BNTX) Historical Enterprise Value (quarterly & annually)

How has BNTX Enterprise Value performed in the past?

The mean historical Enterprise Value of BioNTech SE over the last ten years is 13.95B. The current 16.64B Enterprise Value has changed 11.83% with respect to the historical average. Over the past ten years (40 quarters), BNTX's Enterprise Value was at its highest in in the September 2021 quarter at 55.50B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

BioNTech SE (BNTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioNTech SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioNTech SE (BNTX) Average Enterprise Value

How has BNTX Enterprise Value performed in the past?

The current Enterprise Value of BioNTech SE (BNTX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

BioNTech SE (BNTX) Enterprise Value vs. Peers

How is BNTX’s Enterprise Value compared to its peers?

BioNTech SE’s Enterprise Value is greater than Novavax, Inc. (1.02B), greater than CohBar, Inc. (-4477266.00), greater than Ginkgo Bioworks Holdings, Inc. (242.08M), greater than CRISPR Therapeutics AG (4.09B), less than Ocean Biomedical, Inc. (0), greater than Enveric Biosciences, Inc. (35.97M), greater than Hepion Pharmaceuticals, Inc. (202.96K), greater than Elevation Oncology, Inc. (5.35M), greater than AVROBIO, Inc. (18.49M), greater than PTC Therapeutics, Inc. (-85302404.00), greater than Krystal Biotech, Inc. (3.21B), greater than Sarepta Therapeutics, Inc. (5.10B), greater than Iovance Biotherapeutics, Inc. (12.11B), greater than Madrigal Pharmaceuticals, Inc. (2.52B), greater than null (7.46B),

Build a custom stock screener for BioNTech SE (BNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioNTech SE (BNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.